|
1
|
Brutsaert DL: Cardiac
endothelial-myocardial signaling: Its role in cardiac growth,
contractile performance, and rhythmicity. Physiol Rev. 83:59–115.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Narmoneva DA, Vukmirovic R, Davis ME, Kamm
RD and Lee RT: Endothelial cells promote cardiac myocyte survival
and spatial reorganization: Implications for cardiac regeneration.
Circulation. 110:962–968. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hsieh PC, Davis ME, Lisowski LK and Lee
RT: Endothelial-cardiomyocyte interactions in cardiac development
and repair. Annu Rev Physiol. 68:51–66. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schulz R, Kelm M and Heusch G: Nitric
oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res.
61:402–413. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rezkalla SH and Kloner RA: No-reflow
phenomenon. Circulation. 105:656–662. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Verma S, Fedak PW, Weisel RD, Butany J,
Rao V, Maitland A, Li RK, Dhillon B and Yau TM: Fundamentals of
reperfusion injury for the clinical cardiologist. Circulation.
105:2332–2336. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kalogeris T, Baines CP, Krenz M and
Korthuis RJ: Cell biology of ischemia/reperfusion injury. Int Rev
Cell Mol Biol. 298:229–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lefer AM and Lefer DJ: Pharmacology of the
endothelium in ischemia-reperfusion and circulatory shock. Annu Rev
Pharmacol Toxicol. 33:71–90. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singhal AK, Symons JD, Boudina S, Jaishy B
and Shiu YT: Role of endothelial cells in myocardial
ischemia-reperfusion injury. Vasc Dis Prev. 7:1–14. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eltzschig HK and Collard CD: Vascular
ischaemia and reperfusion injury. Br Med Bull. 70:71–86. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scarabelli T, Stephanou A, Rayment N,
Pasini E, Comini L, Curello S, Ferrari R, Knight R and Latchman D:
Apoptosis of endothelial cells precedes myocyte cell apoptosis in
ischemia/reperfusion injury. Circulation. 104:253–256. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chatauret N, Badet L, Barrou B and Hauet
T: Ischemia-reperfusion: From cell biology to acute kidney injury.
Prog Urol. 24 Suppl 1:S4–S12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leucker TM, Ge ZD, Procknow J, Liu Y, Shi
Y, Bienengraeber M, Warltier DC and Kersten JR: Impairment of
endothelial-myocardial interaction increases the susceptibility of
cardiomyocytes to ischemia/reperfusion injury. PLoS One.
8:e700882013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Majchrzak-Gorecka M, Majewski P, Grygier
B, Murzyn K and Cichy J: Secretory leukocyte protease inhibitor
(SLPI), a multifunctional protein in the host defense response.
Cytokine Growth Factor Rev. 28:79–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schneeberger S, Hautz T, Wahl SM,
Brandacher G, Sucher R, Steinmassl O, Steinmassl P, Wright CD,
Obrist P, Werner ER, et al: The effect of secretory leukocyte
protease inhibitor (SLPI) on ischemia/reperfusion injury in cardiac
transplantation. Am J Transplant. 8:773–782. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Powers SK, Murlasits Z, Wu M and Kavazis
AN: Ischemia-reperfusion-induced cardiac injury: A brief review.
Med Sci Sports Exerc. 39:1529–1536. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jacquet S, Nishino Y, Kumphune S, Sicard
P, Clark JE, Kobayashi KS, Flavell RA, Eickhoff J, Cotten M and
Marber MS: The role of RIP2 in p38 MAPK activation in the stressed
heart. J Biol Chem. 283:11964–11971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen GY and Nuñez G: Sterile inflammation:
Sensing and reacting to damage. Nat Rev Immunol. 10:826–837. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kong Q, Dai L, Wang Y, Zhang X, Li C,
Jiang S, Li Y, Ding Z and Liu L: HSPA12B attenuated acute
myocardial ischemia/reperfusion injury via maintaining endothelial
integrity in a PI3K/Akt/mTOR-dependent Mechanism. Sci Rep.
6:336362016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma G, Greenwell-Wild T, Lei K, Jin W,
Swisher J, Hardegen N, Wild CT and Wahl SM: Secretory leukocyte
protease inhibitor binds to annexin II, a cofactor for macrophage
HIV-1 infection. J Exp Med. 200:1337–1346. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cesarman GM, Guevara CA and Hajjar KA: An
endothelial cell receptor for plasminogen/tissue plasminogen
activator (t-PA). II. Annexin II-mediated enhancement of
t-PA-dependent plasminogen activation. J Biol Chem.
269:21198–21203. 1994.PubMed/NCBI
|
|
22
|
Kumphune S, Surinkaew S, Chattipakorn SC
and Chattipakorn N: Inhibition of p38 MAPK activation protects
cardiac mitochondria from ischemia/reperfusion injury. Pharm Biol.
53:1831–1841. 2015. View Article : Google Scholar : PubMed/NCBI
|
